Picture of Fresenius SE & Co KGaA logo

FRE Fresenius SE & Co KGaA Cashflow Statement

0.000.00%
de flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Annual cashflow statement for Fresenius SE & Co KGaA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line2,8192,1172388671,606
Depreciation
Deferred Taxes
Non-Cash Items42-1162,3188-396
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Changes in Working Capital-534-661403303267
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities5,0784,1984,4202,4152,574
Capital Expenditures-3,046-2,894-1,368-1,003-1,497
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items229287-1,819493682
Sale of Business
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-2,817-2,607-3,187-510-815
Financing Cash Flow Items-60145-1,589-62-6
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-1,452-1,604-1,377-2,183-2,423
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash927-15-187-280-697